BASFY has opened a Mumbai performance lab to provide global technical support and accelerate innovation in superabsorbents and hygiene solutions.

BASF (XTRA:BAS) has drawn fresh attention after the U.S. Food and Drug Administration approved Bemotrizinol as a sunscreen active ingredient, allowing the group to sell its Tinosorb S UV filter in the United States. See our latest analysis for BASF. For investors, the FDA approval comes as BASF trades at €50.99, with the 1-month share price return of 5.04% and a year-to-date share price return of 13.87% sitting alongside a 3-year total shareholder return of 30.87%, which suggests interest in...

Europe’s adaptation to new temperatures could spell profit for other enterprises, such as electricity grids and water systems.

(Bloomberg) -- Europe’s biggest rivers, vital arteries for the region’s heavy industries, are drying up after the region was seared by a series of heat waves. Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesTrump Says US to Hold Off Iran Attack If Rapid Deal Gets AgreedIndia’s Family Offices Embrace Profit-Sharing to Attract Top TalentBessent Joins Japan to Help Reverse Months of Yen LossesMoonshot’s Kimi Uses 20,000 Nvidia Chip Cluster From AlibabaAs wate

BASF (XTRA:BAS) is back in focus after reporting second quarter 2026 earnings, with sales of €17,206 million and net income of €4,144 million, alongside recent product approvals and partnership activity. See our latest analysis for BASF. BASF’s recent earnings release and product news have come alongside a mixed share price pattern, with a 7 day share price return of 3.77% and a 30 day share price return of 7.70% contrasting with a 90 day share price decline of 7.93% and a 1 year total...

CTVA's $2 billion crop-protection pipeline, royalty gains and 2026 split could sharpen its technology-led growth story.

Basf SE (BASFY) reports a 54% increase in EBITDA and a significant net income boost from the Coatings transaction, despite challenges in free cash flow and geopolitical uncertainties.

Basf (ETR:BAS) reported a sharp increase in second-quarter earnings before special items, citing higher prices, volume growth and lower fixed costs, while raising its full-year EBITDA forecast. Chairman of the Board of Executive Directors Markus Kamieth said EBITDA before special items rose 54% in

BASF reported higher revenue and a jump in net profit for the first six months of the year, benefitting from a multi-billion euro disposal gain from its coatings division deal with Carlyle.

BASF pauses the sale of 3,300 apartments as high interest rates and real estate volatility undermine value, while condominium sales continue.

US chemicals companies are likely to report quarterly results in line with expectations, with the Mi

While DOW is expected to have benefited from its cost and productivity actions, soft demand in certain markets is likely to have hurt its Q2 performance.